Author: Brittney Wheeler

Washington University School of Medicine in St. Louis received in 2023 the second highest amount of funding from the National Institutes of Health (NIH) of all medical schools nationwide. This ranking reflects the school’s commitment to cutting-edge research and positions it as a key player in shaping the future of medicine.

Julie K. Schwarz, MD, PhD, a highly regarded radiation oncologist known for her innovative mindset in treating patients and leading research to develop new treatments for deadly gynecologic cancers and heart conditions, has been named a William H. Danforth Washington University Physician Scholar.

Yin Cao, ScD, of Washington University School of Medicine in St. Louis, is leading an international team seeking to understand what is driving the increase in early-onset colorectal cancer globally. To do so, her team has received funding from Cancer Grand Challenges, co-founded by Cancer Research UK and the National Cancer Institute, part of the National Institutes of Health (NIH).

Children ages 3 to 6 who have had clinical depression are more likely than their peers to have attempted suicide or to have had thoughts of killing themselves by age 12, according to a new study by researchers at Washington University in St. Louis.

Celina Jacobi, MD, an instructor in child psychiatry, and Lisa Zickuhr, MD, an assistant professor of medicine, have been named the 2024-26 Carol B. and Jerome T. Loeb Teaching Fellows at the School of Medicine.

Renée Shellhaas, MD, the David T. Blasingame Professor of Neurology at the School of Medicine, has been elected to the American Epilepsy Society board of directors.

Washington University School of Medicine in St. Louis is one of seven U.S. institutions joining a new national clinical trials network launched by the National Cancer Institute, part of the National Institutes of Health (NIH), to investigate emerging technologies for cancer screening, with the goal of reducing cancer-related illnesses and deaths.

Three early-career scientists at the School of Medicine have been honored with the Young Physician-Scientist Award by the American Society for Clinical Investigation (ASCI). They are Tarin M. Bigley, MD, PhD; Jeffrey W. Brown MD, PhD; and Drew J. Schwartz, MD, PhD.

GatewaySeq, a genetic test that identifies cancer mutations in solid tumors and that was developed by researchers at Washington University School of Medicine in St. Louis, has been approved for reimbursement by the Centers for Medicare & Medicaid Services.

Researchers at Washington University School of Medicine in St. Louis and Lund University in Sweden showed that a blood test is as good at identifying people in early stages of the disease as cerebrospinal fluid tests approved by the Food and Drug Administration for Alzheimer’s diagnosis.